Learn, Analyse & Invest
only with
only with
+91
Download Orca
Concord Drugs Ltd.
Concord Drugs
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹1.12 Cr.
| EX-Date | Purpose |
|---|---|
| 28 06 2021 | Audited Results |
| 13 08 2021 | Quarterly Results |
| 18 10 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results |
| 06 08 2022 | Quarterly Results |
| 07 09 2022 | Preferential Issue of shares & Inter alia, to consider and approve Raising of funds for expansion of business and to explore new options for inorganic growth. |
| 14 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 27 03 2023 | Inter alia, to consider and approve:- 1. Conversion of warrants into equity shares to the Promoters pursuant to the allotment of the same in the board meeting held on 07.11.2022. 2. Acquisition of Proton Remedies Private Limited as approved by the shareholders in the Annual General Meeting held on 30.09.2022. 3. Any other business with the permission of the Chair. |
| 30 05 2023 | Audited Results |
| 14 08 2023 | Quarterly Results |
| 14 11 2023 | Quarterly Results |
| 13 02 2024 | Quarterly Results |
| 13 11 2024 | Quarterly Results |
| 11 01 2025 | Quarterly Results |
| 13 03 2025 | Preferential Issue of shares & Increase in Authorised Capital Inter alia, to consider the following agenda items: 1. Raising of funds for expansion of business and to explore new options by way of issue of Preferential Allotment. 2. Increase in Authorized share Capital and to make subsequent alteration in Memorandum of Association of the Company. 3. Confirmation for Proposed Date, Time and Venue for holding Extra Ordinary General Meeting of the Company. 4. Any other business with the permission of the Chair. |
| 17 03 2025 | Increase in Authorised Capital & Inter alia, to consider and approve: 1. Increase in Authorised Capital 2. Issue of shares on Preferential Allotment 3. Any other matter with the permission of chair |
| 23 05 2025 | Audited Results |
| 27 06 2025 | Preferential Issue of shares & Inter alia, to consider and approve the following business items: 1. To consider and approve the proposal for raising of funds for business expansion purposes, including but not limited to, by way of Preferential Allotment or such other permissible mode(s), subject to necessary approvals. 2. To consider and approve the date, time, and venue for convening an ExtraOrdinary General Meeting of the Company for obtaining shareholders? approval, wherever required. 3. To transact any other matter with the permission of the Chair. |
| 03 07 2025 | Preferential Issue of shares & Increase in Authorised Capital |
| 08 08 2025 | Quarterly Results |
| 13 11 2025 | Quarterly Results |
| 14 02 2026 | Quarterly Results |
News
